ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,454 Cr | ₹1,114 Cr | ₹631 Cr | ₹865 Cr | ₹809 Cr |
What is the latest Total Current Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,454 Cr |
| Mar2025 | ₹1,114 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹865 Cr |
| Mar2022 | ₹809 Cr |
How is Total Current Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,454 Cr | 30.57 | |
| Mar2025 | ₹1,114 Cr | 76.59 | |
| Mar2024 | ₹631 Cr | -27.12 | |
| Mar2023 | ₹865 Cr | 6.99 | |
| Mar2022 | ₹809 Cr | - | |
Compare Total Current Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,003.9 Cr | 17.8% | 0.2% | -14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 17.8% |
0.2% |
-14.7% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses